Mexican athlete’s foot brand making its way across the border to U.S. Hispanic markets
EL SEGUNDO, Calif. — MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete’s foot treatment in Mexico.
The brand is expanding its U.S. distribution and can be found at such retailers as Walmart and Target in key U.S. Hispanic markets, such as Los Angeles, Houston, Dallas and Chicago, the company said.
"As the summer season gets into full swing and the incidence of athlete’s foot reaches its peak, we are launching a TV campaign to promote Conazol’s availability in the U.S. and support our retail partners," MarxasUSA CEO Richard Phillips said. According to Phillips, MarcasUSA will begin TV promotion in June on multiple Hispanic TV networks in eight markets across the U.S. Additionally, the company will kick off a sweepstakes promotion on Facebook.
Conazol contains miconazole Nnitrate 2% antifungal as its active ingredient and is manufactured in Mexico by Liomont Labs.
Marley Coffee announces distribution deal with Fresh & Easy
LOS ANGELES — Marley Coffee has expanded its retail presence by inking a new deal with Fresh & Easy, Tesco’s U.S. subsidiary.
The retailer, which operates 197 stores across Arizona, Nevada and California, now will offer Marley Coffee organic ground 8-oz. bags in One Love 100% Ethiopian Yirgacheffe (medium roast), Buffalo Solider (dark) and Get Up Stand Up (light) varieties.
"We continue to increase our retail presence for Marley Coffee and drive sales, and we’re excited to work with Fresh & Easy Neighborhood Market to expand our distribution on the West coast and into the Southwest," Marley Coffee CEO Brent Toevs said. "Fresh & Easy is an excellent addition to our movement, as we continue to make Marley Coffee available to coffee fans across the nation."
Tris Pharma, Perrigo to bring Delsym generic equivalent to market
MONMOUTH JUNCTION, N.J. — Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser’s Delsym, an extended-release oral liquid suspension containing dextromethorphan.
Delsym was approved in 1982 and there has never been any generic alternative approved until now, the company noted. "This is the third extended-release liquid product approved by the FDA based on our patented technology, and speaks to Tris’ capabilities to develop and commercialize difficult products," Tris Pharma president and CEO Ketan Mehta said.
Perrigo will be Tris’ exclusive partner in distributing this product as a store-brand alternative to Delsym for the coming cough-cold-flu season. Annual sales across the entire Delsym brand are estimated at more than $100 million, Tris Pharma said.